Resolution criteria

Each option will resolve to "Yes" if The New York Times publishes an article mentioning "Herasight" by the end of the specified date. Verification will be based on a search of The New York Times archives. If no such article is found by the end of the specified date, the option will resolve to "No."

Background

Herasight is a company specializing in comprehensive carrier screening and assisting parents with in vitro fertilization (IVF) using advanced whole genome technologies. (herasight.com)

Considerations

As of August 2025, there are no known articles in The New York Times mentioning Herasight. Traders should consider the company's activities, press releases, and industry developments when making predictions.

Thanks to AI for helping to write the question.

Update (August 29): I sold my share and will no longer bet in this market.